Finance

Beta
Lists
ALC:NYSE
Alcon AG
US$ ६६.११
-२.६४%
(-१.७९) 1D
US$ ६७.०३
+१.३९% (+०.९२)
Pre-market
Closed: जुन १०, १६:००:१० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALC...
Open
US$ ६७.०३
High
US$ ६७.३३
Low
US$ ६६.१०
Mkt. cap
२६.८३ अरब
Avg. vol.
२५.०० लाख
Volume
१.०८ हजार
52-wk high
US$ ९२.५५
52-wk low
US$ ६१.८४
Beta
०.८८
Shares outstanding
४९.१२ करोड
No. of employees
२५ हजार
Open
US$ ६७.०३
High
US$ ६७.३३
Low
US$ ६६.१०
Mkt. cap
२६.८३ अरब
Avg. vol.
२५.०० लाख
Volume
१.०८ हजार
52-wk high
US$ ९२.५५
52-wk low
US$ ६१.८४
Beta
०.८८
Shares outstanding
४९.१२ करोड
No. of employees
२५ हजार
News stories
From sources across the web
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees२५ हजार
Founded१९४५
Headquartersजेनेभा, Geneva, स्विट्जरल्यान्ड
Sector-
Websitealcon.com
Last report
२०२६ मे ६
Fiscal period
Q1 2026
EPS / Est. (USD)
US$ ०.८५ / US$ ०.८२
+४.०६%beat
Revenue / Est. (USD)
२.७१ अरब / २.७१ अरब
-०.११%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
२.६० अरब
२.६१ अरब
२.७२ अरब
२.७१ अरब
Cost of goods sold
१.१६ अरब
१.१६ अरब
१.२० अरब
१.१८ अरब
Cost of revenue
१.१६ अरब
१.१६ अरब
१.२० अरब
१.१८ अरब
Research and development expenses
२४.५० करोड
२४.८० करोड
२७.३० करोड
२४.५० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८७.०० करोड
८६.५० करोड
९०.१० करोड
८८.२० करोड
Operating expense
१.१४ अरब
१.१२ अरब
१.२० अरब
१.२३ अरब
Total operating expenses
२.३१ अरब
२.२८ अरब
२.४० अरब
२.४१ अरब
Operating income
२९.०० करोड
३३.६० करोड
३१.८० करोड
२९.२० करोड
Other non operating income
-
३०.०० लाख
-२.८० करोड
-
EBT including unusual items
१९.९० करोड
२८.३० करोड
२६.४० करोड
२४.०० करोड
EBT excluding unusual items
२४.२० करोड
२८.७० करोड
२७.१० करोड
२४.०० करोड
Income tax expense
२.३० करोड
४.६० करोड
४.७० करोड
५.१० करोड
Effective tax rate
११.५६%
१६.२५%
१७.८०%
२१.२५%
Other operating expenses
२.६० करोड
९०.०० लाख
२.६० करोड
१०.६० करोड
Net income
१७.६० करोड
२३.७० करोड
२१.७० करोड
१८.९० करोड
Net profit margin
६.७८%
९.०७%
७.९८%
६.९८%
Earnings per share
०.७६
०.७९
०.७८
०.८५
Interest and investment income
४०.०० लाख
-
७.४० करोड
२०.०० लाख
Interest expense
-५.१० करोड
-५.१० करोड
-५.३० करोड
-५.२० करोड
Net interest expenses
-४.७० करोड
-५.१० करोड
२.१० करोड
-५.०० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
४८.७० करोड
७८.४० करोड
४४.१० करोड
५५.२० करोड
Gain or loss from assets sale
१०.०० लाख
५०.०० लाख
९०.०० लाख
२०.०० लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer